» Articles » PMID: 34351702

In Vitro Strategies to Vascularize 3D Physiologically Relevant Models

Overview
Journal Adv Sci (Weinh)
Date 2021 Aug 5
PMID 34351702
Citations 36
Authors
Affiliations
Soon will be listed here.
Abstract

Vascularization of 3D models represents a major challenge of tissue engineering and a key prerequisite for their clinical and industrial application. The use of prevascularized models built from dedicated materials could solve some of the actual limitations, such as suboptimal integration of the bioconstructs within the host tissue, and would provide more in vivo-like perfusable tissue and organ-specific platforms. In the last decade, the fabrication of vascularized physiologically relevant 3D constructs has been attempted by numerous tissue engineering strategies, which are classified here in microfluidic technology, 3D coculture models, namely, spheroids and organoids, and biofabrication. In this review, the recent advancements in prevascularization techniques and the increasing use of natural and synthetic materials to build physiological organ-specific models are discussed. Current drawbacks of each technology, future perspectives, and translation of vascularized tissue constructs toward clinics, pharmaceutical field, and industry are also presented. By combining complementary strategies, these models are envisioned to be successfully used for regenerative medicine and drug development in a near future.

Citing Articles

Rethinking Biomedical Titanium Alloy Design: A Review of Challenges from Biological and Manufacturing Perspectives.

Rabbitt D, Villapun V, Carter L, Man K, Lowther M, OKelly P Adv Healthc Mater. 2024; 14(4):e2403129.

PMID: 39711273 PMC: 11804846. DOI: 10.1002/adhm.202403129.


Bioengineered human arterial equivalent and its applications from vascular graft to disease modeling.

Luo X, Pang Z, Li J, Anh M, Kim B, Gao G iScience. 2024; 27(11):111215.

PMID: 39555400 PMC: 11565542. DOI: 10.1016/j.isci.2024.111215.


vascularization of 3D cell aggregates in microwells with integrated vascular beds.

Fois M, Tahmasebi Birgani Z, Lopez-Iglesias C, Knoops K, van Blitterswijk C, Giselbrecht S Mater Today Bio. 2024; 29:101260.

PMID: 39391792 PMC: 11466645. DOI: 10.1016/j.mtbio.2024.101260.


A 3D Bio-Printed-Based Model for Pancreatic Ductal Adenocarcinoma.

Godier C, Baka Z, Lamy L, Gribova V, Marchal P, Lavalle P Diseases. 2024; 12(9).

PMID: 39329875 PMC: 11431387. DOI: 10.3390/diseases12090206.


Revitalizing liver function in mice with liver failure through transplantation of 3D-bioprinted liver with expanded primary hepatocytes.

Deng B, Ma Y, Huang J, He R, Luo M, Mao L Sci Adv. 2024; 10(23):eado1550.

PMID: 38848358 PMC: 11160470. DOI: 10.1126/sciadv.ado1550.


References
1.
Leucht A, Volz A, Rogal J, Borchers K, Kluger P . Advanced gelatin-based vascularization bioinks for extrusion-based bioprinting of vascularized bone equivalents. Sci Rep. 2020; 10(1):5330. PMC: 7093518. DOI: 10.1038/s41598-020-62166-w. View

2.
Martin G, Timpl R . Laminin and other basement membrane components. Annu Rev Cell Biol. 1987; 3:57-85. DOI: 10.1146/annurev.cb.03.110187.000421. View

3.
Kimura H, Sakai Y, Fujii T . Organ/body-on-a-chip based on microfluidic technology for drug discovery. Drug Metab Pharmacokinet. 2017; 33(1):43-48. DOI: 10.1016/j.dmpk.2017.11.003. View

4.
Velasco V, Shariati S, Esfandyarpour R . Microtechnology-based methods for organoid models. Microsyst Nanoeng. 2021; 6:76. PMC: 8433138. DOI: 10.1038/s41378-020-00185-3. View

5.
Liu J, Zheng H, Poh P, Machens H, Schilling A . Hydrogels for Engineering of Perfusable Vascular Networks. Int J Mol Sci. 2015; 16(7):15997-6016. PMC: 4519935. DOI: 10.3390/ijms160715997. View